Article
CD44 splice variants: expression during lymphocyte activation and tumor progression.
Behring Institute Mitteilungen - 1 Aug 1993
Pals S T, Koopman G, Heider K H, Griffioen A, Adolf G R, Van den Berg F, Ponta H, Herrlich P, Horst E
Abstract excerpt
A recently described splice variant of CD44 has been shown to confer metastatic potential to non-metastasizing rat pancreatic carcinoma and sarcoma cell lines. Using antibodies raised against a bacterial fusion protein encoded by variant CD44 sequences, we have explored the expression of variant CD44 glycoproteins in human lymphoid cells and tissues, in non-Hodgkin's lymphomas, and in colorectal neoplasia. Normal...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.